Research programme: monomethyl fumarate prodrugs - Alkermes plcAlternative Names: AKLS-MMF; ALKS MMF; MMF prodrug program - Alkermes; RDC-1559
Latest Information Update: 19 Jul 2013
At a glance
- Originator Alkermes plc
- Class Fumarates; Small molecules
- Mechanism of Action Immunomodulators; NF E2 related factor 2 stimulants; NF-kappa B inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Multiple sclerosis
Most Recent Events
- 17 Jul 2013 Preclinical trials in Multiple sclerosis in Ireland (PO)